ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000778.1|Lipopolysaccharide_1 # 1 # 444 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.550	BGC0000778.1|Lipopolysaccharide_1 	1	444	-	Loose	375	45.0542	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	34.92	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAACCAGAGACAGGATCATTCATAGCGCCACCGAGCTGTTCAACGATCAGGGTGAGCGCAACATCACCACCAACCACATTGCCGCGCATCTTGGCATCAGCCCTGGCAACCTTTATTACCACTTCAGGAATAAAGAAGACATCATCCACTCGATTTTTGATCAATACGCCCGCCACCTGAGCGAGAGCTTCACCCCGGCGCGCAGCAACGAGATCAAGCTGGAAAACCTGATGGGCTACCTGGATGCCATCTTCTATCTGATGTGGCAGTTCCGCTTCTTCTACGCAAATCTACCGGACATCCTGAGTCGCGATGAGCCGCTGCAGCAAAAATACCTCAAGGCCCAGGAGCAGTTGCGTTCCTCCGTGGTCGCCCTGCTCAGGAGCCTGCGTGAAGGGGGGATCATTGACGTCAACGACGAAGACCTGCCCGACCTTGGC	MKTRDRIIHSATELFNDQGERNITTNHIAAHLGISPGNLYYHFRNKEDIIHSIFDQYARHLSESFTPARSNEIKLENLMGYLDAIFYLMWQFRFFYANLPDILSRDEPLQQKYLKAQEQLRSSVVALLRSLREGGIIDVNDEDLPDLG	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	68.84	gnl|BL_ORD_ID|2090|hsp_num:0	2306			30	204	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000778.1|Lipopolysaccharide_2 # 591 # 1550 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.566	BGC0000778.1|Lipopolysaccharide_2 	591	1550	+	Loose	1200	43.8986	arnA	23.6	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGATCGTAGTAACTGGCGGTGCTGGCTTTATCGGCAGCAATCTGGTCAAGCAGCTGAACGCTCAAGGACGGACCGACATCGTGGTCATCGATGACCTGACCGACGGCACCAAGTTCGTCAACCTGGTCGATCTGACCATTGCCGATTACATGGATAAGGACGAGTTCCAGGCGCGGATCGTCTCCGGTGACGAGTTTGAAGAGTGGGACGACGGCATCGAGGTGATCTTCCACGAAGGTGCCTGCTCCGCGACCACTGAGTGGAACGGCAAGTTCATCATGGAGGTCAATTACGAGTACTCCAAGGATCTGTTCCACTACTGCATCGAGCGGGAAATCCCGTTTATTTACGCCTCCTCCGCCGCGACCTACGGTGGCCGCAACGACAACTTCATCGAAGATCCCAAGTTCGAGCAGCCGCTCAACGTCTATGGCTACTCCAAGCAGCTGTTCGACCAGTACGTGCGCCGCTGGATGCCGGAGATCAACTCCCAGGTCGTGGGTCTGAAGTATTTCAACGTCTACGGTCCGCGCGAGCAACACAAGGGCTCCATGGCTTCCGTTGCCTTCCACCTCAATACTCAGGTGAAGAAGGGCGAGAATCCCAAGCTGTTCGAAGGCTGTGACGGTTTCCCGAACGGTGGCCAGATGCGTGACTTCATCTATGTGGATGACGTCTGCAAGGTGAATCTCTGGTTCTGGCAGAACCCGCAGCACTCCGGCATCTTCAACTGCGGTACCGGTCGTGCCGAGCCGTTCCAGAACGTGGCCGAAGCCGTGATCCAGCATCATCAGAAAGGGGCAATCGAGTACATTCCCTTCCCGGATCACCTCAAGGGTCGCTATCAGAGCTTCACTCAGGCAGACATGACCAGGCTGCGCGGTGTCGGTTATGACGCCGAGTTCAAGACTGTGGCCGAAGGCGTGGCCGATTACATGGCCTGGTTGAACCGGGTTTGA	MIVVTGGAGFIGSNLVKQLNAQGRTDIVVIDDLTDGTKFVNLVDLTIADYMDKDEFQARIVSGDEFEEWDDGIEVIFHEGACSATTEWNGKFIMEVNYEYSKDLFHYCIEREIPFIYASSAATYGGRNDNFIEDPKFEQPLNVYGYSKQLFDQYVRRWMPEINSQVVGLKYFNVYGPREQHKGSMASVAFHLNTQVKKGENPKLFEGCDGFPNGGQMRDFIYVDDVCKVNLWFWQNPQHSGIFNCGTGRAEPFQNVAEAVIQHHQKGAIEYIPFPDHLKGRYQSFTQADMTRLRGVGYDAEFKTVAEGVADYMAWLNRV	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	48.19	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1629	polymyxin B
BGC0000778.1|Lipopolysaccharide_3 # 1601 # 3361 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.567	BGC0000778.1|Lipopolysaccharide_3 	1601	3361	+	Loose	700	56.9954	LpsB	24.85	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAACATATTGATGGCACTCTCCCAGCTCGAAGTGACGGGAGCTGAGGTCTATGCCACCACGGTCGGTAACGAATTGACCCGACGTGGTCATCAGGTTTTCTACGTATCGGACACGCTGACCAAGCCTACCCAGGGCCCCGTGTTCAAGCTGCGTTTCAACAAGCGCAGCATACTGCGCCGCTTCTGGCATGTGTTTTATCTCATCTACCTCATCAAGAAGCACCATATCCAGTTAGTGCATGCACACTCTCGAGCCTCCGGCTGGAGCAGCTATGTTGCCTGCAAGCTGACCGGCACTCCCATGGTTACCACGGTACATGGCCGCCAGCCGGTGCATGCCTCCCGCAAGGCTTTCCATGCCCTCGGGTTCAGGGCCGTGGCCGTCTGCGAGGATATTGCCCACCAGATCATCGACAATCTGGGGGTGGATCCGGCCATAGTGCAGGTGCTGCGCAACGGCATCGAGACTGACAAGTTTCAGCCAGTGCCAGCACCGGACAATGCAACGCCGGTGATCGCCATCATAGGGCGGCTGAGCGGCCCCAAGGGCGAGCTCTGCTATCGTCTGCTGGACGAGGTGCTGGATCTGGATGCCTGTCAGGTAAGGGTGGTGAGTGGCAGCCAGCTGCCTGAGCGTTTCCACCGCTTTCAGAGTCAGGTCGATTTCGTCGGTTATGTGGATGATGTCCCTACCTTGCTGGCGGGATGTGATCTGGTGATCGGTGCAGGCCGGGTGGCGATGGAGGCGTTGCTGTGCGGGCGTCCCGCTTTTGCCATCGGCGAGGCCAAGGCGATTGGTCTGGTGACCGAACAGAATCTAGCGGAGGCGCTGGCCAGCAACTTCGGCGACATAGGCCCCCAGGATCTGGCGATCGACTTCAGTGCCTTGAAGACAGAGATAGCACCCGCATTGGCCAGCAAGAGTGTGCCTGAGGCCATTCGCCAGCGCATTCAGGATGAGTATGGCTTGGAGAAAGTAGTATCCGGGCTGGAATCCATCTATCAGGATGCGGTGGTCGAGACCCTGCGCCGCGAGATGCCTGTCATCATGTACCACCGTTTTATCGAGCATGACAGCGAGAAGGGGGTACATGGTACCTGGATGCCTATTGCCATGTTCGAGAAGCATCTTCGTTTAATGAAATGGCTGGGTTATGAAACTCTGACTTTCCGCGATCTGGCGGACAGGGGCTTTATCCATCGTCTTGAATACGGCAAGAAGTACCTGATGATCACCGCCGATGACGGCTATCAGGACAACCTGACGCGCATGCTGCCGTTGCTTGAAAAATACGGTTACAAAGCCGTGGTATATGTGGTGACCGGAGAGGCGCATAATCGCTGGGATGTGGAGCATGCCACCAACCCGGATACCCAGGTTTCCCTGATGAATGGGGAGCAGATAAAGGCCCTTGTGGCCTCTGGCCATGTGGAAGTCGGTGGCCACACCCTGACTCATCCCAGGTTGAGCGAGCTCTCTCCTGAGCGGCAAGTCCATGAAATAAGAGAAAACAAACGACAACTCGAGGCCTTGCTAGGTCACTCTCTGCTGTCGTTCGCCTACCCTTATGGGGATATGGACGAGAGCGCCAAGGTGCAGGCACAGGCAGCAGGCTACCGTTTTGCCGTGGCGACCAACAGTGGTCCCAGAGCCATGCATCAGGATCCTTACCGGATCCGTCGCATCGCCATTTTCCCTCGTACCGATGTTTTTGGCCTGTGGCGCAAAATCCGGGGTAACTATGTCTTCAGGAAATAA	MNILMALSQLEVTGAEVYATTVGNELTRRGHQVFYVSDTLTKPTQGPVFKLRFNKRSILRRFWHVFYLIYLIKKHHIQLVHAHSRASGWSSYVACKLTGTPMVTTVHGRQPVHASRKAFHALGFRAVAVCEDIAHQIIDNLGVDPAIVQVLRNGIETDKFQPVPAPDNATPVIAIIGRLSGPKGELCYRLLDEVLDLDACQVRVVSGSQLPERFHRFQSQVDFVGYVDDVPTLLAGCDLVIGAGRVAMEALLCGRPAFAIGEAKAIGLVTEQNLAEALASNFGDIGPQDLAIDFSALKTEIAPALASKSVPEAIRQRIQDEYGLEKVVSGLESIYQDAVVETLRREMPVIMYHRFIEHDSEKGVHGTWMPIAMFEKHLRLMKWLGYETLTFRDLADRGFIHRLEYGKKYLMITADDGYQDNLTRMLPLLEKYGYKAVVYVVTGEAHNRWDVEHATNPDTQVSLMNGEQIKALVASGHVEVGGHTLTHPRLSELSPERQVHEIRENKRQLEALLGHSLLSFAYPYGDMDESAKVQAQAAGYRFAVATNSGPRAMHQDPYRIRRIAIFPRTDVFGLWRKIRGNYVFRK	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	160.11	gnl|BL_ORD_ID|2781|hsp_num:0	3793			0	966	colistin A; colistin B; defensin
BGC0000778.1|Lipopolysaccharide_4 # 3368 # 4579 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.507	BGC0000778.1|Lipopolysaccharide_4 	3368	4579	+	Loose	1020	27.7202	vgaE	26.56	3002833	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGCCCATCAGATGCCTTTATCTGCTCGATAAAACCACCACAGCCCTGTTTGCATTGACCATCATTTTTTCCTTTTGCGGCCTTTTTTTGGTACCTGCCGGCCAGAGCATTGAATCTAATCTGCTGGCCGTGACCGGCATATTTGGCTTGCTGAACTACTTTGTCGGCAAGCAACAAGATGTTGGACTGAAAGATCGCCGCATTCTCTGGGGACTGGTAGTGTATGCCGCCATGATTTTCGTCAACCGGTTGATTCATGGTGATCAATATGGGGTCATGCGCGGGCTGTTTTATGTTGTTATCTTTGCACTGATGATGCCGCGCAAGCCAATTCTATTGATGCTGGGTTATCTGGCTATCGTCCTGGGCGGGATGGGACTGGGAATGCTCAGCATCTGGCAGTATCAGCATGGTATGGTCAGGGTTGAAGGGTTTACCAACGCCATTCTCTTTTCACAAGCAGCATTGACGCTGGCGATCCTCAACTGGTTTGTCTTTCAGCAGAGATGGCTGCCTAGATGGTTTCGGAGGGGGGCTCTTATTGGCCTGATTGCGGCCCTGTTTGCGCTTTATCTCTCCCAGAGCCGGGGGGTCTGGCTTGCCCTCGGGGTCATTCTTGCCTACGTCATCTGTTACAAGGCCTATTTCAAGCCGTGGAAATACGTTGCGGTAGCCATATTGTGTACGGCCACGACGGGCGCCATTTATCATACCAATCAGCTGGTTCAGGTTCGGGTCGCGGAGGCGGTCTCGGATATCAACTCGGCAGAAAAGGGCTCGTACGATTCATCGTGGGGTCTGCGTGTCATTGCCTGGCAGAGTGCCTGGCTGGGTTTTTTGGATTCGCCTGTGGCAGGAGTGGGCACTGATGGCTTCGACGCATTGAAACAAACCCAGATCAATAATCATCAGGTCTCTCCCCTGATATTTCATCCGGCGCTGGTCCACTCGCATAATCAATATATGCAGAACCTGGTGGTTCGAGGCGGCATCGGATTTGTTGCATTGGTGATATTTCTTGGCCTGCCGCTCTATTTTGCCGCGAAAAATATAAACAGGATTTCTGCAGGGGTACTGGTGCCTCTGGCGTTTGCGATTAATTCGCTAAGCGATGTTCCGTTTGAACATCAAGGGGTGCTCTATTTGTATACGCTCAGCCTGGTTTTCATCTGGTTTGCCCATGAGTTTGAAAAGGATACCTGTACGTCATGA	MPIRCLYLLDKTTTALFALTIIFSFCGLFLVPAGQSIESNLLAVTGIFGLLNYFVGKQQDVGLKDRRILWGLVVYAAMIFVNRLIHGDQYGVMRGLFYVVIFALMMPRKPILLMLGYLAIVLGGMGLGMLSIWQYQHGMVRVEGFTNAILFSQAALTLAILNWFVFQQRWLPRWFRRGALIGLIAALFALYLSQSRGVWLALGVILAYVICYKAYFKPWKYVAVAILCTATTGAIYHTNQLVQVRVAEAVSDINSAEKGSYDSSWGLRVIAWQSAWLGFLDSPVAGVGTDGFDALKQTQINNHQVSPLIFHPALVHSHNQYMQNLVVRGGIGFVALVIFLGLPLYFAAKNINRISAGVLVPLAFAINSLSDVPFEHQGVLYLYTLSLVFIWFAHEFEKDTCTS	MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL	76.91	gnl|BL_ORD_ID|1490|hsp_num:0	1626			18	210	clindamycin; virginiamycin M1; tiamulin
BGC0000778.1|Lipopolysaccharide_5 # 4576 # 5241 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.550	BGC0000778.1|Lipopolysaccharide_5 	4576	5241	+	Loose	500	64.3142	LpsA	28.96	3005052	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGATTCCGGTTTTTGTCATCAGTTTGGCTCGCAGCGTTGAGCGGCGGGCGATGGTTGTACAGCAGATGGCGCATCTGGGCATCAATTTCGAGTTCGTAGATGCGACCGATGGGAAAGCATTGAGCAGCGCGGAACTTGCCAAGGTTGACTTGGAGCTGGCCAAAGAAGTGTGTGGCCATGAGCTGAGTTTTGGTGAGATTGGCTGTGCCATGAGCCATATCCGTGTTTATGAGCGCATAGTCGCCGAGGGAATTGATCGCTGCGTGGCGTTGGAAGATGACATTTACCTGCACATGCACAGCAAGGCGATCATCGAGACGATAGTGCGCTCCTGCCATTCGGAGATCGTCTTCCTGCATCATGGCAAAGCCAAGCGCTGGCCAATTCTTTCCTCCTTGCCGGGTGGTTATCGGCTTGCCAGATATCTGGCACCGAGTCGCACCTCCAGGAGAGGGATCCTGTCGACCGCAGGGTATGTTCTGACCCTGGCCGGGGCGAAGAAATTATTGCAGTGTGCTTATCCGCTGCGCATGCCTTCCGATTATCTGACTGGTCGCCTGCAGCTTAATGGCCTGGCTGCCTCCGGTGTTGAGCCCTGCTGCCTGGATGTGGATCTCTTTACCACCACGATTGATGATCGGGCTTACGGCCACTATCTGGAATAG	MIPVFVISLARSVERRAMVVQQMAHLGINFEFVDATDGKALSSAELAKVDLELAKEVCGHELSFGEIGCAMSHIRVYERIVAEGIDRCVALEDDIYLHMHSKAIIETIVRSCHSEIVFLHHGKAKRWPILSSLPGGYRLARYLAPSRTSRRGILSTAGYVLTLAGAKKLLQCAYPLRMPSDYLTGRLQLNGLAASGVEPCCLDVDLFTTTIDDRAYGHYLE	MHNAAQHNYVISLTTEQKRRKHITEEFGKQNIPFEFFDAITPDIIEETAKKFNITLDRSPKAKLSDGEIGCALSHIVLWDLALENNLNYINIFEDDIHLGENAKELLEIDYISDDIHVLKLEANGKMFFKQPKSVKCDRNVYPMTVKQSGCAGYTVTAKGAKYLLELVKNKPLDVAVDSLVFEDFLHFKDYKIVQLSPGICVQDFVLHPDNPFESSLQEGRDRVHGNQRKFSILEKIKNEFGRVKIKMFGKQVPFK	86.33	gnl|BL_ORD_ID|2782|hsp_num:0	3794			24	540	polymyxin B; defensin
BGC0000778.1|Lipopolysaccharide_7 # 6410 # 7522 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.592	BGC0000778.1|Lipopolysaccharide_7 	6410	7522	+	Loose	700	30.8018	vanS gene in vanA cluster	27.42	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGTCATTAATCAACGACCTGCAACTCAAGCGTGACATTCTTCGCCGCAAGATGGGACGGTTCCTGTTTGATCGAAAACGGCCTGAACCCACCAGGGAGAGCGAGGGGAAAGTCGTCCTGCTGCGCTGGGATGCCAAACTGGGCGATGCGATCGTCTCGTCCTGGGTGGCCCGCGAACTAAAGCGGGTCAACCCGGCACGTGAGGTGTGGATCGTTACAACGGCAGCCATGGCTCCCCTGTTTCGCGATCATTTCGGCATGGATAGGGTCATCGAGGTGCCCAAGCGCCCCGGTTATTGTCAACTCAGGCGGCTTGCACTGTCATTGGGGGAGGTCGGTTGCCTGGTTCACTTTGGCAAGATGTTGAAGATGAAGGATATCTTTTTCATCAGCCAGGTCAGGGCAGATTGGGTCGCCGGCATGGACGACGCCTTGCAGGCCATCAATCTCAAGCTGGGAGCCGCGTCCAGAGGTATGCACTTCTCCGACAAGTTTGCCCTGCTGTTGAATCGACTCGGAGTGGCAGACCCGGATCAGCGCTACATCATCCCCGCTCCGGGTCAGGAGGCGTCGGTTGCGAGCTGGTGGCCCGATGATGTCGTGCTCTGCTTCAACCCTTATGGCAGCGGTAGTTCCCGCCGTCTGAAGCCGGAGCTGATCCGGCAGATGCTGGAGAGGATGCTGGACGCCTGCCCATTTGCCATCTGCCTGCTTTATCCACCGGGTATGGAGGCTGAAGTAGCGGGGATCCGGGCCGGGCTCACCCGACCCGAGCGCATGGTATTGTCACCCGATGCGCCCTCGCTGGCGGGCCTTTTCGCCCAGTTGCGTCAGAGCCAGGGCCTCATTTCGGTGGATACGGCGACCATACATATCGCGGCCGGGCTGGAGCAACCCATTCTGGGTCTCTACAACCCGGATATAGGGGGTGGCAACGAGAATTTCCTGGAATGGCATCCCAACTCCCCGTTGGCGACCGTGCTGTTCTCGGAGAATCTCCGCGAACAGGACATCAACTCTCTCAACCTGACCGAGTTCGACCGGCTATTCAGGCAGTGGCTACTTGCCAATCAGGCAGCGCTGTCAGTCGGGCAATCACCAGCTCAGGCGTAA	MSLINDLQLKRDILRRKMGRFLFDRKRPEPTRESEGKVVLLRWDAKLGDAIVSSWVARELKRVNPAREVWIVTTAAMAPLFRDHFGMDRVIEVPKRPGYCQLRRLALSLGEVGCLVHFGKMLKMKDIFFISQVRADWVAGMDDALQAINLKLGAASRGMHFSDKFALLLNRLGVADPDQRYIIPAPGQEASVASWWPDDVVLCFNPYGSGSSRRLKPELIRQMLERMLDACPFAICLLYPPGMEAEVAGIRAGLTRPERMVLSPDAPSLAGLFAQLRQSQGLISVDTATIHIAAGLEQPILGLYNPDIGGGNENFLEWHPNSPLATVLFSENLREQDINSLNLTEFDRLFRQWLLANQAALSVGQSPAQA	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	96.35	gnl|BL_ORD_ID|1809|hsp_num:0	1907			750	936	vancomycin; teicoplanin
BGC0000778.1|Lipopolysaccharide_8 # 7458 # 8525 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.584	BGC0000778.1|Lipopolysaccharide_8 	7458	8525	-	Loose	175	26.1794	vanT gene in vanG cluster	38.64	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAAATACCTTGTAGTACAAACCAAACAGATAGGGGATGTACTGATCTCCACCGCGCTGTGCAACAACCTCAAGCAGAACGATCCAACCGGGGAAGTTCACTATCTGGTCATGGATTATTGCGCGGGTATGGCGCAGGGCAATCCCAATATCGATCGACTCCTCATCATCGAGAAAGCCAGGCGCAACGACTGGCGCTACATGAAAGACCTGCTGCTGGACATCCGCCGCGAACACTATGACGTGGTAGTCAACAGCCAGGGCCAGATGATAGGCCTGCTGACCTGCCTCTTCTCCGGCGCCAGGTTGCGGATAGGATTTGACTCCTTCCCCTGGCGGCTCGGCCACAACCGCATAGTGCGCTTTCGCAAAGACACCGAATTCCAGGGCAACAGTACCCTGATCGACGACCGCTTCTCGCTGCTCAAACCGCTCAAACTGGCCAAAGAAGATCGCAATTACCATCTCTGGCTGAGCGAAGAGGAGAAGCTGCAGGGACGGGAAACCTTGCAGGCGGCTGGCGTCGATCTCGCACGGCCCTTGATCGCCATGGGCGTCAACTCGCTGGGGCACTACAAGCGCTGGCCCATCGACTGCTTCGCCCAGGTTGCCCAGTGGCTCATCGAACAGCACAACGCCCAGATCCTGATCTACTGCGGGCCGGGAGAAGAGGAGTACAACCGCGGTCTCAAGCCGCTGCTGCCTGCCGCCTTGCAGGGAAGCGTGTTTGATCAGATCAAGACCCGCTCGGTACGGGAGCTGGTAGGGCTGTTCGCCCATTGCCAACTGTTTGTCGGCAACGATACCGGCCCCCGCCACATGGCCCAGGCCATCGACCTGCCCCTGCTGACCATAGTGGCTCCCGGCGGCGACAAGATCATCGCCAATCCGGTCAACCACCCCCGCTATCAGGCCATCGATATCTTCGATGCCAAGGGCGCCGACTTCCAGCTGCCGCAAAATGCGGAGAAAGACTTCATCGATGAAACCCTGTTGCGCGCCATTACGCCTGAGCTGGTGATTGCCCGACTGACAGCGCTGCCTGATTGGCAAGTAGCCACTGCCTGA	MKYLVVQTKQIGDVLISTALCNNLKQNDPTGEVHYLVMDYCAGMAQGNPNIDRLLIIEKARRNDWRYMKDLLLDIRREHYDVVVNSQGQMIGLLTCLFSGARLRIGFDSFPWRLGHNRIVRFRKDTEFQGNSTLIDDRFSLLKPLKLAKEDRNYHLWLSEEEKLQGRETLQAAGVDLARPLIAMGVNSLGHYKRWPIDCFAQVAQWLIEQHNAQILIYCGPGEEEYNRGLKPLLPAALQGSVFDQIKTRSVRELVGLFAHCQLFVGNDTGPRHMAQAIDLPLLTIVAPGGDKIIANPVNHPRYQAIDIFDAKGADFQLPQNAEKDFIDETLLRAITPELVIARLTALPDWQVATA	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	49.86	gnl|BL_ORD_ID|1522|hsp_num:0	1561			1218	1350	vancomycin
